Global Bovine Respiratory Disease Treatment to grow at a CAGR of 8.11% during the period 2017 - 2021; Finds New Report

Report forecast the global bovine respiratory disease treatment to grow at a CAGR of 8.11% during the period 2017-2021.

Bovine respiratory disease is a multifactorial and complex disorder caused due to a combination of more than one microbial pathogens, inadequate housing conditions, impaired host immunity, and environmental factors.

The report covers the present scenario and the growth prospects of the global bovine respiratory disease treatment for 2017-2021. To calculate the market size, the report considers the include sales of branded drugs, generic drugs, and vaccines.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, one of the major drivers for this market is development of novel products. The development of novel products is expected to bring substantial growth opportunities in the market. The launch of new products will substantially increase the adoption rates, thereby driving the market growth. Traditionally, antibiotics and vaccines are typically used for the treatment of BRD. To gain competitive advantage, vendors are focusing on developing novel drugs to drive growth and profitability substantially.

Further, the report states that one of the major factors hindering the growth of this market is high cost of therapies coupled with presence of natural alternatives. The high cost of drugs may hinder the growth prospects in the market. The direct cost of treatment of BRD in feedlot cattle is substantial at $23.60 per case. These costs had almost doubled since 1999 when the cost of treatment was $12.59 per case. The high cost of therapies could be due to the presence of branded products for the treatment of BRD.

Global Bovine Respiratory Disease Treatment 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global bovine respiratory disease treatment: Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, and Zoetis.

Other Prominent Vendors in the market are: Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Norbrook Laboratories, and Plumbline Life Sciences.

Market driver

• Development of novel products
• For a full, detailed list, view our report

Market challenge

• High cost of therapies coupled with presence of natural alternatives
• For a full, detailed list, view our report

Market trend

• Growing focus on the development of combination drugs
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages and 43 Exhibits “Global Bovine Respiratory Disease Treatment 2017 - 2021” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, An overview of bovine respiratory disease, Market segmentation by product category, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/UTa

Related Reports;

Global Arthroscopy Devices Market 2017-2021 - Visit at - http://mrr.cm/UTR

Global Antiviral Drugs Market 2017-2021 - Visit at - http://mrr.cm/UTD